PATRICIA O'CONNELL: Open Payments
NPI 1982145769 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 54 payments from 11 companies in 2025. Trend: 2023 $1,804 · 2024 $1,491 · 2025 $1,550
Food & beverage: $1,550
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $379 |
| Axsome Therapeutics, Inc. | 6 | $233 |
| Alkermes, Inc. | 5 | $209 |
| ABBVIE INC. | 15 | $153 |
| Neurocrine BioSciences, Inc. | 3 | $149 |
| Otsuka America Pharmaceutical, Inc. | 3 | $127 |
| Novo Nordisk Inc | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
Products named: CAPLYTA, Auvelity, VRAYLAR, INGREZZA, LYBALVI, REXULTI, Wegovy, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
